APOE and early-onset autosomal dominant Alzheimer disease: Though NODDI has shown promise in studies of normal ageing,8,30 early-onset Alzheimer’s disease,34 and other tauopathies,32 there is currently insufficient data to draw conclusions about the influence of APOE ɛ4 on grey matter NODDI measurements in cognitively normal midlife adults.